Thompson Peter A.'s Form 4 filing
Alpine Immune Sciences, Inc. (ALPN) · filed Dec 29, 2023
- Accession no.
- 0000947871-23-001190
- Filed
- Dec 29, 2023
- Trade date
- Dec 27-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $28.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Peter A.CIK 0001357522 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | Common Stock | SSaleDisposed | −162,576 | $19.96 | −$3,245,016.96 | 3,493,485 | Indirect | |
| Dec 27, 2023 | Common Stock | SSaleDisposed | −18,922 | $19.96 | −$377,683.12 | 406,609 | Indirect | |
| Dec 28, 2023 | Common Stock | SSaleDisposed | −26,872 | $19.82 | −$532,603.04 | 3,466,613 | Indirect | |
| Dec 28, 2023 | Common Stock | SSaleDisposed | −3,128 | $19.82 | −$61,996.96 | 403,481 | Indirect | |
| Dec 28, 2023 | Common Stock | SSaleDisposed | −1,195,683 | $18.32 | −$21,904,912.56 | 2,270,930 | Indirect | |
| Dec 28, 2023 | Common Stock | SSaleDisposed | −139,166 | $18.32 | −$2,549,521.12 | 264,315 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.